AiM GmbH - Assessment in Medicine

It’s finally here! We’re excited to announce that our updated Reimbursement of Medical Devices in 🇩🇪 Germany 2024/2025 brochure is now available on our website. In addition to the essential information on the German market, this new edition includes details on the numerous changes to the German #reimbursement system since our last publication. Whether you’re looking to refresh your knowledge or get up to speed on the latest updates, this guide has you covered! Access our new guide here: https://lnkd.in/g2g_V_AM For those interested in an official printed copy, physical editions will be available for pickup at #MEDICA2024 at our booth (Hall 14 / D21 - IGES Institut). If you have any questions about reimbursement in Germany, or if you'd like to discuss the key updates in the brochure, don’t hesitate to reach out to set up an initial consultation. You can also find Michael Weisser or Christian Minnie at MEDICA - Leading International Trade Fair to discuss reimbursement in Germany in person. #marketaccess #medtech #medicaldevice

#MEDICA2024 is just one week away! As usual, the lead-up to MEDICA - Leading International Trade Fair can get quite busy. If you're interested in 🇩🇪 Germany or the broader 🇪🇺 European market, you can connect with AiM CEO, Michael Weisser, and International Business Specialist, Christian Minnie, at the IGES Group booth located in Hall 14 / Booth D21, within the Berlin-Brandenburg region. Feel free to drop them a message or stop by to say hello in person. They're excited to meet you in Düsseldorf! #marketaccess #reimbursement #medtech #medicaldevice

Did you know that 🇩🇪 Germany has reworked how reimbursement for 🩹 wound care products works from the bottom up? Previously, there were no specific definitions for wound care products, leading to immediate coverage in the German #reimbursement system upon launch. Now, #woundcare products have been defined and classified by the G-BA. Definitions now include three categories: bandages, bandages with additional properties and other products for wound treatment. The other products for wound treatment category requires special attention, as this might necessitate an HTA to get coverage under Annex Va of the Drug Guideline. At the same time, there is a scientific consultation to inquire about evidence requirements! If you are visiting #MEDICA2024 and are wondering how your would care product fits into these new classifications, AiM CEO, Michael Weisser and International Business Specialist, Christian Minnie, will be there to talk with you about how your device can take advantage of these new opportunities. If you would like to organize a meeting with them at MEDICA, feel free to contact us or just look for them at the Berlin-Brandenburg region booth in Hall 14 /Booth D21 from November 11th to 14th. We look forward to seeing you at MEDICA 2024! #marketaccess #medtech

Did you know that 🇩🇪 Germany raised the risk class acceptable for digital applications (Medical devices)? The #DiGA scheme has been a leader in the European introduction of digital apps to the statutory health system. Previously, DiGA compatible applications could only be low risk class (I/IIa). Now the accepted risk class includes IIb. DiGA devices must still be able to primarily provide a benefit to a patient by its digital function, not solely by physician involvement. If you are visiting #MEDICA2024 and are wondering if your digital app can enter Germany through the DiGA pathway, AiM CEO, Michael Weisser and International Business Specialist, Christian Minnie, will be there to talk with you about how your device can take advantage of these new opportunities. If you would like to organize a meeting with them at MEDICA, feel free to contact us or just look for them at the Berlin-Brandenburg region booth in Hall 14 /Booth D21 from November 11th to 14th. We look forward to seeing you at MEDICA 2024! #marketaccess #medtech #reimbursement

Did you know that 🇩🇪 Germany is increasing their focus on outpatient care? Through the ongoing reforms, Germany has created a new type of #reimbursement scheme to finance specific outpatient procedures through the DRG system: HybridDRGs. Additionally, the AOP catalog, or list of outpatient procedures executable in a hospital setting, is undergoing further expansion. With these changes, the outpatient reimbursement landscape has never been so dynamic! If you are visiting #MEDICA2024 and have a #medicaldevice that can be used in the outpatient setting (or can even be used in inpatient as well), AiM CEO, Michael Weisser and International Business Specialist, Christian Minnie, will be there to talk with you about how your device can take advantage of these new opportunities. If you would like to organize a meeting with them at MEDICA, feel free to contact us or just look for them at the Berlin-Brandenburg region booth in Hall 14 /Booth D21 from November 11th to 14th. We look forward to seeing you at MEDICA 2024! #medtech #marketaccess

Market access in 🇩🇪 Germany is pretty complicated, eh? In collaboration with the 🇨🇦 Trade Commissioner Service | Service des délégués commerciaux in Germany, AiM is here to provide clarity on pathways and opportunities for #marketaccess in Germany. In this 60-minute Pre-MEDICA Webinar, AiM CEO, Michael Weisser, will help Canadian companies planning to visit #MEDICA2024 understand the facets of market access and #reimbursement in Germany to get the most out of their discussions during their stay. The webinar will cover: 🏥 The structure of the reimbursement system in Germany 🚀The different pathways to enter the market 🔄 Important ongoing changes 💡 How your company can capitalize on these developments 📅 The Pre-MEDICA webinar will take place on Oct. 29, 2024 at 5 PM CET*. ⚠️ Note: this webinar is exclusively available to 🇨🇦 Canadian Companies *🕟 Also keep in mind, daylight savings in Germany is on Oct. 27th, while Canada is on Nov. 3rd, meaning Germany’s time zone will be an hour closer than usual. Lastly, AiM would like to wish all of our friends and partners in Canada a Happy #Thanksgiving! 🦃🍁🥧 You can find out more and register using this link: https://lnkd.in/gPuxjf_D #medtech

It’s that time of the year again! 🎉 AiM CEO, Michael Weisser and International Business Specialist, Christian Minnie, will be at MEDICA 2024 from 📅 November 11th to 14th. With the ongoing changes and new #reimbursement pathways opened up for medical devices in 🇩🇪 Germany, Michael and Christian would be happy to discuss how your device or technology can take advantage of these new opportunities. They will, once again, be presenting with the IGES Group booth at the Berlin-Brandenburg region in📍Hall 14/Booth D21. If you would like to organize a meeting with them at MEDICA - Leading International Trade Fair, feel free to contact us at info@aim.iges.com or just look for them on the floor 👋. We look forward to seeing you at #MEDICA2024 ! #medtech #marketaccess #medicaldevice

Wir stellen ein! Mehr Infos im Post unten ⬇️ #Hiring #Karriere #medtech #reimbursement #marketaccess

Do you have a #medicaldevice that helps to be cost-efficient? 💶   As the financing and care landscapes evolve, 🇩🇪 German hospitals are under increasing pressure to optimize costs without compromising patient care. This challenging landscape makes cost-efficient medical devices more critical than ever.   At AiM, we're here to help you adapt to the market's financial constraints. We offer comprehensive support to build your case for #costefficiency in Germany, including:   📈 ROI calculators tailored to your device 💡 Strategic argumentation framing 🔍 Primary research to assess the strength of your arguments   Don’t hesitate to reach out to AiM. Together, we can turn these challenges into opportunities and thrive in this evolving healthcare environment. 🚀 #reimbursement #marketaccess #medtech

Do you have a #medicaldevice that helps to be cost-efficient? 💶   As the financing and care landscapes evolve, 🇩🇪 German hospitals are under increasing pressure to optimize costs without compromising patient care. This challenging landscape makes cost-efficient medical devices more critical than ever.   At AiM, we're here to help you adapt to the market's financial constraints. We offer comprehensive support to build your case for #costefficiency in Germany, including:   📈 ROI calculators tailored to your device 💡 Strategic argumentation framing 🔍 Primary research to assess the strength of your arguments   Don’t hesitate to reach out to AiM. Together, we can turn these challenges into opportunities and thrive in this evolving healthcare environment. 🚀 #reimbursement #marketaccess #medtech